ERp29 Activators refer to a class of chemical compounds that have the ability to influence the activation or function of the Endoplasmic Reticulum Protein 29 (ERP29) within the cellular environment. ERP29, a chaperone protein primarily located in the endoplasmic reticulum (ER), plays a pivotal role in maintaining protein quality control, proper protein folding, and the unfolded protein response (UPR) within the ER. Chemicals falling under the category of ERp29 Activators modulate the activity of ERP29, thereby impacting critical cellular processes. These compounds interact with various signaling pathways and cellular mechanisms that regulate the activation or expression of ERP29, ensuring the protein's optimal function.
ERp29 Activators often exert their influence by targeting specific cellular pathways associated with ER stress responses, protein folding, and protein trafficking. For instance, some chemicals in this class can induce ER stress, prompting the activation of UPR pathways, ultimately leading to the upregulation or enhanced function of ERP29. Others may act as chaperone inducers, promoting correct protein folding within the ER and indirectly supporting the activation of ERP29 in its role as a chaperone protein. Additionally, some ERp29 Activators may impact the expression of proteins involved in the Nrf2 pathway, leading to enhanced ERP29 activity by bolstering the ER's ability to respond to stress and maintain protein integrity. By influencing various cellular processes and pathways, ERp29 Activators offer valuable tools for studying the intricate cellular mechanisms related to protein quality control and ER homeostasis, expanding our understanding of these fundamental biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Activates the Nrf2 pathway, indirectly promoting ERP29 activation by enhancing cellular stress response mechanisms in the endoplasmic reticulum. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Enhances the cellular antioxidant capacity, indirectly supporting the activation of ERP29 by reducing oxidative stress and promoting proper protein folding in the endoplasmic reticulum. | ||||||
4-Phenylbutyric acid | 1821-12-1 | sc-232961 sc-232961A sc-232961B | 25 g 100 g 500 g | $53.00 $136.00 $418.00 | 10 | |
Promotes proper protein folding and endoplasmic reticulum stress activation, potentially impacting ERP29 through the maintenance of protein quality control mechanisms. | ||||||
GSK 2606414 | 1337531-36-8 | sc-490182 sc-490182A | 5 mg 25 mg | $163.00 $572.00 | ||
Inhibits PERK kinase, a key regulator of the unfolded protein response (UPR), potentially affecting the activation of ERP29 and related pathways in response to ER stress. | ||||||
Apocynin | 498-02-2 | sc-203321 sc-203321A sc-203321B sc-203321C | 1 g 10 g 100 g 500 g | $27.00 $68.00 $116.00 $360.00 | 74 | |
Activates NADPH oxidase inhibition, reducing oxidative stress in the endoplasmic reticulum and promoting proper ERP29 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Induces autophagy, a process linked to endoplasmic reticulum protein quality control, which may indirectly promote ERP29 activation. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Activates endoplasmic reticulum stress responses by releasing nitric oxide, potentially impacting ERP29 activation and related pathways. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
Modulates endoplasmic reticulum-associated degradation (ERAD) processes, indirectly promoting ERP29-related pathways and protein quality control mechanisms in the ER. | ||||||